Financials Indiva Limited

Equities

NDVA

CA45580J1012

Pharmaceuticals

Market Closed - Toronto S.E. 03:02:39 2024-05-01 pm EDT 5-day change 1st Jan Change
0.065 CAD -7.14% Intraday chart for Indiva Limited -7.14% -31.58%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 32.38 20.48 30.13 51.67 15.47 17.69
Enterprise Value (EV) 1 17.22 28.6 43.31 70.83 34.69 37.44
P/E ratio -3.55 x -1.79 x -1.7 x -3.18 x -1.3 x -3.17 x
Yield - - - - - -
Capitalization / Revenue 555 x 22.2 x 2.06 x 1.59 x 0.45 x 0.47 x
EV / Revenue 295 x 31 x 2.96 x 2.18 x 1.01 x 1 x
EV / EBITDA -2.51 x -3 x -4.95 x -13.5 x -5.93 x -21.7 x
EV / FCF -2.08 x -1.77 x -6.9 x -5.87 x 10.8 x -9.7 x
FCF Yield -48.1% -56.5% -14.5% -17% 9.25% -10.3%
Price to Book 1.1 x 1.06 x 2.69 x 4.21 x 7.2 x -51.7 x
Nbr of stocks (in thousands) 83,036 83,588 109,556 145,537 147,297 186,245
Reference price 2 0.3900 0.2450 0.2750 0.3550 0.1050 0.0950
Announcement Date 4/30/19 5/15/20 5/13/21 4/26/22 4/17/23 4/25/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.0583 0.9239 14.65 32.47 34.4 37.57
EBITDA 1 -6.853 -9.52 -8.751 -5.229 -5.847 -1.722
EBIT 1 -7.26 -10.1 -8.886 -5.34 -6.098 -2.116
Operating Margin -12,451.65% -1,092.91% -60.65% -16.44% -17.73% -5.63%
Earnings before Tax (EBT) 1 -8.656 -11.4 -15.42 -15.28 -11.05 -4.918
Net income 1 -8.527 -11.4 -15.42 -15.01 -10.93 -4.918
Net margin -14,623.68% -1,233.72% -105.27% -46.22% -31.78% -13.09%
EPS 2 -0.1100 -0.1371 -0.1613 -0.1116 -0.0810 -0.0300
Free Cash Flow 1 -8.279 -16.15 -6.28 -12.06 3.21 -3.859
FCF margin -14,198.66% -1,748.05% -42.86% -37.15% 9.33% -10.27%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/30/19 5/15/20 5/13/21 4/26/22 4/17/23 4/25/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales 1 7.718 9.454 8.945 8.891 8.091 9.307 9.412 7.506 9.787 10.87
EBITDA 1 0.1708 -0.4938 -1.464 -0.1496 -0.4988 -0.5566 0.4148 -0.6103 1.042 1.509
EBIT -0.7974 -2.198 -1.674 - - - - - - -
Operating Margin -10.33% -23.25% -18.72% - - - - - - -
Earnings before Tax (EBT) -6.43 -4.134 -3.026 - - - - - - -
Net income -6.43 -4.134 -3.026 - - - - - - -
Net margin -83.32% -43.73% -33.83% - - - - - - -
EPS 2 -0.0500 -0.0300 -0.0200 -0.0200 -0.0200 -0.0200 -0.0200 -0.0100 - -
Dividend per Share - - - - - - - - - -
Announcement Date 11/16/21 4/26/22 5/18/22 8/16/22 11/22/22 4/17/23 5/16/23 8/29/23 11/21/23 4/25/24
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 8.12 13.2 19.2 19.2 19.7
Net Cash position 1 15.2 - - - - -
Leverage (Debt/EBITDA) - -0.8531 x -1.507 x -3.664 x -3.288 x -11.47 x
Free Cash Flow 1 -8.28 -16.1 -6.28 -12.1 3.21 -3.86
ROE (net income / shareholders' equity) -35.4% -46.8% -101% -127% -154% -545%
ROA (Net income/ Total Assets) -14.3% -17.1% -14.4% -8.18% -9.49% -3.49%
Assets 1 59.56 66.78 107.3 183.5 115.2 140.7
Book Value Per Share 2 0.3500 0.2300 0.1000 0.0800 0.0100 -0
Cash Flow per Share 2 0.2400 0.0100 0 0.0200 0.0200 0.0100
Capex 1 3.71 11.5 2.32 1.8 1.07 0.54
Capex / Sales 6,358.88% 1,244.39% 15.83% 5.53% 3.1% 1.43%
Announcement Date 4/30/19 5/15/20 5/13/21 4/26/22 4/17/23 4/25/24
1CAD in Million2CAD
Estimates
  1. Stock Market
  2. Equities
  3. NDVA Stock
  4. Financials Indiva Limited